Last reviewed · How we verify

NCT05977634

Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder

Active, enrolled NA Last updated 9 April 2026
What this trial tests

NA trial testing Bladder training in Overactive Bladder in 26 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
30 September 2023
Primary endpoint
30 July 2026
30 August 2026

Quick facts

Lead sponsorEge University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment26
Start date30 September 2023
Primary completion30 July 2026
Estimated completion30 August 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 18 to 70, female only, with Overactive Bladder or Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed to assess the efficacy of trans cutaneous tibial nerve stimulation on symptoms of overactive bladder in women with idiopathic overactive bladder

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bladder training

Trials testing the same drug.

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05977634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing